The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.
In Avert’s revealing new podcast series we hear from people whose lives have been affected by HIV.
Research from South Africa suggests a women’s HIV risk may be driven more by their male partner’s age rather than the age gap between them.
A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group.
A new low-cost, low-tech method for predicting an adult’s risk of developing tuberculosis (TB) could represent a major step forward for TB prevention.
Although the risk of developing cancer is decreasing for people living with HIV as antiretroviral treatment (ART) improves, it remains higher for certain cancers – and as ART expands, this burden is expected to grow.
The majority of migrants living with HIV in Europe became infected after arriving to their new country – debunking the previously held assumption that HIV infections among migrants are imported.
Savings would be ‘small and transient’ – raising significant ethical and efficacy concerns about the benefit of US budget cuts for HIV programming abroad.
Landmark Lancet study shows the benefit of a simplified approach to HIV testing, diagnosis and linking to care for people living with HIV in a middle-income country.
HIV programmes must develop strategies and allocate resources for people who enter the ‘failure care cascade’ – or risk jeopardising the important gains already made on HIV treatment.
